Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...
HINGHAM, MA – Microbot Medical Inc. (NASDAQ:MBOT), a clinical-stage medical device company with a market capitalization of $43.2 million, announced significant developments, including fundraising ...
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results